Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference154 articles.
1. Targeting FAK in human cancer: from finding to first clinical trials;Golubovskaya;Front. Biosci. (Landmark Ed.),2014
2. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions;Schaller;Proc. Natl. Acad. Sci. USA,1992
3. Molecular pathways: endothelial Cell FAK-A target for cancer treatment;Roy-Luzarraga;Clin. Cancer Res.,2016
4. Emerging roles of focal adhesion kinase in cancer;Tai;Biomed. Res. Int.,2015
5. Targeting FAK scaffold functions inhibits human renal cell carcinoma growth;Béraud;Int. J. Cancer,2015
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bucidarasin A suppresses the proliferation and metastasis of HCC by targeting the FAK and STAT3 pathways;Chemico-Biological Interactions;2024-10
2. Focal adhesion kinase-mediated interaction between tumor and immune cells in the tumor microenvironment: implications for cancer-associated therapies and tumor progression;Clinical and Translational Oncology;2024-09-13
3. Probing the protrusions: lamellipodia and filopodia in cancer invasion and beyond;Mechanobiology in Medicine;2024-06
4. CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway;BMC Cancer;2024-05-27
5. Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive Review;Current Cancer Drug Targets;2024-04-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3